Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial-Reference-Cited by-同舟云学术

Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial

Published:2015 Issue:3 Volume:56 Page:228-239
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Fujishiro Mitsuhiro¹,Higuchi Kazuhide²,Kato Mototsugu³,Kinoshita Yoshikazu⁴,Iwakiri Ryuichi⁵,Watanabe Toshio⁶,Takeuchi Toshihisa²,Sugisaki Nobuyuki⁷,Okada Yasushi⁸,Ogawa Hisao⁹¹⁰,Arakawa Tetsuo⁶,Fujimoto Kazuma¹¹,

Affiliation:

1. Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo

2. Second Department of Internal Medicine, Osaka Medical College

3. Division of Endoscopy, Hokkaido University Hospital

4. Department of Internal Medicine II, Faculty of Medicine, Shimane University

5. Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School

6. Department of Gastroenterology, Osaka City University Graduate School of Medicine

7. Clinical Development, Japan/Asia Clinical Research Product Creation Unit, Eisai Product Creation Systems, Eisai Co., Ltd.

8. Clinical Research Institute and Cerebrovascular Medicine, National Hospital Organization, Kyushu Medical Center

9. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University

10. National Cerebral and Cardiovascular Center

11. Department of Internal Medicine, Saga Medical School

Publisher

The Society for Free Radical Research Japan

Subject

Clinical Biochemistry,Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.jstage.jst.go.jp/article/jcbn/56/3/56_15-1/_pdf

Reference59 articles.

1. 1 Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86. Erratum in: BMJ 2002; 324: 141.

2. 2 Yasue H, Ogawa H, Tanaka H, et al. Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators. Am J Cardiol 1999; 83: 1308–1313.

3. 3 Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 2002; 162: 2197–2202.

4. 4 Nema H, Kato M, Katsurada T, et al. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease. J Gastroenterol Hepatol 2008; 23 Suppl 2: S234–S236.

5. 5 Sakamoto C, Sugano K, Ota S, et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol 2006; 62: 765–772.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle;Cureus;2024-01-23

2. Cardiovascular Compatibility of Proton Pump Inhibitors: Practice Recommendations;Cardiology and Therapy;2023-11-10

3. Long-term proton pump inhibitors use and its association with premalignant gastric lesions: a systematic review and meta-analysis;Frontiers in Pharmacology;2023-08-25

4. Rabeprazole Coadministration Controls Ulcer Recurrence in Patients on Low-dose Aspirin Therapy: A Multicenter Prospective Study;Internal Medicine;2023-02-15

5. Effect of a rabeprazole half-dose twice daily on acid inhibition in patients with different CYP2C19 alleles;European Journal of Clinical Pharmacology;2020-06-02